|
Pharmacovigilance
Pharmacovigilance
is the science and activities relating to detection, assessment,
understanding and prevention of adverse effects or any other possible
medicine related problem. It aims in making best use of medicines for the
treatment or prevention of diseases. Though it is not intended to harm the
patients during medicine use process, unfortunately some medicines often
cause problems. Significant harm to even a few patients not only destroys the
credibility of the medicine, the patients too loose
trust on the care professional or the health system.
Good Pharmacovigilance
will identify the risks and the risk factors in the shortest possible time so
that the harm can be avoided or minimized. The integration of Pharmacovigilance may be crucial to the success of public
health programmes involving medicines. Under the
stimulus and coordination of World Health Organization (WHO) and its
Collaborating Centre for International Drug Monitoring (Uppsala Monitoring
Centre: www.who-umc.org ), National programmes are built up to make it a true international
necessity.
The provision of good
quality, safe and effective medicines and their appropriate use is the
responsibility of national governments. The government of India has launched
the National Pharmacovigilance programmes through Central Drug Standard Control Organization (CDSCO: www.cdsco.nic.in/html/pharmaco.html
). The adverse drug reaction reporting form can be downloaded from the CDSCO website. The list of banned drugs can be seen at: http://www.cdsco.nic.in/ .
 Reports
 Symposium cum Workshop on
National Pharmacovigilance Programme
Links Drug Alerts WHO Pharmaceutical
Newsletter
|
